{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:56:07Z","timestamp":1792000567545,"version":"4.4.0"},"reference-count":141,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>From finger-stick blood glucose monitoring and mechanical insulin pens in the 1970s to modern automated insulin delivery systems, rapidly progressing advances in diabetes technology are transforming management options for people with diabetes, particularly those with type 1 diabetes but also, increasingly, people with type 2 diabetes. However, access to life-changing diabetes technologies is neither uniform nor universally covered, and there is no one-size-fits-all approach. In this position statement, we emphasize to health care professionals the importance of supporting individuals with diabetes to access and use the right diabetes technology according to personal needs, capabilities, and preferences. In doing so, we highlight the equal importance of avoiding disparities in the provision of diabetes technology by challenging preconceived barriers, which can be overcome with education and determination. We also make a series of suggestions for action to advance the more widespread adoption of diabetes technology while minimizing the \u201cdigital divide.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title\/>\n                  <\/jats:sec>","DOI":"10.2337\/dci26-0018","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:01:40Z","timestamp":1773327700000},"page":"916-930","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":5,"title":["Challenges in and Opportunities for Individualizing Diabetes Technology: A Position Statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group"],"prefix":"10.2337","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-8955","authenticated-orcid":false,"given":"Daniela","family":"Bruttomesso","sequence":"first","affiliation":[{"name":"Unit of Metabolic Diseases, Department of Medicine, University of Padova 1 , Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4894-9819","authenticated-orcid":false,"given":"John R.","family":"Petrie","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, College of Medical, Veterinary and Life Sciences, University of Glasgow 2 , Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Evans","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science, University of Cambridge 3 , Cambridge, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Alexander","family":"Fleming","sequence":"additional","affiliation":[{"name":"Kinexum, Harpers Ferry 4 , WV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Hanaire","sequence":"additional","affiliation":[{"name":"Department of Diabetology, University Hospital of Toulouse, University of Toulouse 5 , Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm 6 , Ulm, Germany"},{"name":"German Center for Diabetes Research (DZD) 7 , Munich-Neuherberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Sherr","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine 8 , New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Bergenstal","sequence":"additional","affiliation":[{"name":"International Diabetes Center and HealthPartners Institute 9 , Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-1304","authenticated-orcid":false,"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[{"name":"Science & Co. 10 , D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Peters","sequence":"additional","affiliation":[{"name":"Keck School of Medicine and the Leonard D. Schaeffer Institute for Public Policy & Government Service, University of Southern California 11 , Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"2026061016265912100_B1","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.2337\/dc25-S007","article-title":"7. Diabetes technology: Standards of Care in Diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B2","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-022-05744-z","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association","volume":"66","author":"Sherr","year":"2023","journal-title":"Diabetologia"},{"key":"2026061016265912100_B4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/dci23-0001","article-title":"Overview of social determinants of health in the development of diabetes","volume":"46","author":"Hill-Briggs","year":"2023","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B5","doi-asserted-by":"crossref","first-page":"e63288","DOI":"10.2196\/63288","article-title":"eHealth literacy and health-related internet use among Swedish primary health care visitors: cross-sectional questionnaire study","volume":"8","author":"Sj\u00f6str\u00f6m","year":"2024","journal-title":"JMIR Form Res"},{"key":"2026061016265912100_B6","doi-asserted-by":"crossref","first-page":"e53932","DOI":"10.2196\/53932","article-title":"Opportunities to address specialty care deserts and the digital divide through the Veterans Health Administration\u2019s Telehealth Hub-and-Spoke Cardiology Clinic: retrospective cohort study","volume":"26","author":"Tisdale","year":"2024","journal-title":"J Med Internet Res"},{"key":"2026061016265912100_B7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00125-021-05578-1","article-title":"Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study","volume":"65","author":"Jeyam","year":"2022","journal-title":"Diabetologia"},{"key":"2026061016265912100_B8","doi-asserted-by":"crossref","first-page":"e3842","DOI":"10.1002\/dmrr.3842","article-title":"Efficacy and safety of different hybrid closed loop systems for automated insulin delivery in people with type 1 diabetes: a systematic review and network meta-analysis","volume":"40","author":"Di Molfetta","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026061016265912100_B9","doi-asserted-by":"crossref","first-page":"e70043","DOI":"10.1002\/edm2.70043","article-title":"Long-term performance of two systems for automated insulin delivery in adults with type 1 diabetes: an observational study","volume":"8","author":"Fisker","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"2026061016265912100_B10","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1177\/19322968241234948","article-title":"Comparative effectiveness of hybrid closed-loop automated insulin delivery systems among patients with type 1 diabetes","volume":"19","author":"Folk","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"2026061016265912100_B11","unstructured":"DigiBete.\n          \n          Type 1 technology & resources, 2025. Accessed 16 January 2025. Available from https:\/\/www.digibete.org\/type-1-technology-resources\/"},{"key":"2026061016265912100_B12","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s13300-024-01654-y","article-title":"Criteria for personalised choice of a continuous glucose monitoring system: an expert opinion","volume":"15","author":"Di Molfetta","year":"2024","journal-title":"Diabetes Ther"},{"key":"2026061016265912100_B13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00125-015-3513-z","article-title":"Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group","volume":"58","author":"Heinemann","year":"2015","journal-title":"Diabetologia"},{"key":"2026061016265912100_B14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/dci17-0043","article-title":"Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group","volume":"40","author":"Petrie","year":"2017","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B15","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.2337\/dci22-0018","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association","volume":"45","author":"Sherr","year":"2022","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B16","doi-asserted-by":"crossref","first-page":"bvae210","DOI":"10.1210\/jendso\/bvae210","article-title":"Disparities in diabetes technology uptake in youth and young adults with type 1 diabetes: a global perspective","volume":"9","author":"Conway","year":"2024","journal-title":"J Endocr Soc"},{"key":"2026061016265912100_B17","unstructured":"Scottish Government\n          . Increasing access to diabetes technology. Published 23 June 2023. Accessed 2 December 2025. Available from https:\/\/www.gov.scot\/news\/increasing-access-to-diabetes-technology"},{"key":"2026061016265912100_B18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000543654","article-title":"Automated insulin delivery systems for treatment of type 1 diabetes: strategies for optimal performance","volume":"98","author":"Nimri","year":"2025","journal-title":"Horm Res Paediatr"},{"key":"2026061016265912100_B19","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1111\/dom.16499","article-title":"Fully automated insulin delivery systems in type 1 diabetes: a systematic review and meta-analysis","volume":"27","author":"Fan","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026061016265912100_B20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13098-023-01144-4","article-title":"Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials","volume":"15","author":"Godoi","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"2026061016265912100_B21","doi-asserted-by":"crossref","first-page":"101637","DOI":"10.1016\/j.diabet.2025.101637","article-title":"Practical implementation of automated insulin delivery systems in 2025: a French position statement update","volume":"51","author":"Bismuth","year":"2025","journal-title":"Diabetes Metab"},{"key":"2026061016265912100_B22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026061016265912100_B23","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"key":"2026061016265912100_B24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/dia.2024.0197","article-title":"Long-term improvements in glycemic control with Dexcom CGM use in adults with noninsulin-treated type 2 diabetes","volume":"26","author":"Layne","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41574-024-00973-1","article-title":"Continuous glucose monitoring for the routine care of type 2 diabetes mellitus","volume":"20","author":"Ajjan","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"2026061016265912100_B26","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s13300-024-01607-5","article-title":"Perspective of continuous glucose monitoring-based interventions at the various stages of type 2 diabetes","volume":"15","author":"Ajjan","year":"2024","journal-title":"Diabetes Ther"},{"key":"2026061016265912100_B27","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2337\/dci24-0023","article-title":"Response to Comment on Seidu et al. Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence. Diabetes Care 2024;47:169\u2013179","volume":"47","author":"Seidu","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1210\/clinem\/dgae626","article-title":"Defining continuous glucose monitor time in range in a large, community-based cohort without diabetes","volume":"110","author":"Spartano","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061016265912100_B29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/19322968241242487","article-title":"Continuous glucose monitoring for prediabetes: what are the best metrics?","volume":"18","author":"Zahalka","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"2026061016265912100_B30","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3390\/nu16142218","article-title":"Personalized nutrition therapy without weight loss counseling produces weight loss in individuals with prediabetes who are overweight\/obese: a randomized controlled trial","volume":"16","author":"Basiri","year":"2024","journal-title":"Nutrients"},{"key":"2026061016265912100_B31","doi-asserted-by":"crossref","first-page":"7687694","DOI":"10.1155\/2024\/7687694","article-title":"Adding a brief continuous glucose monitoring intervention to the National Diabetes Prevention Program: a multimethod feasibility study","volume":"2024","author":"Richardson","year":"2024","journal-title":"J Diabetes Res"},{"key":"2026061016265912100_B32","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s13300-021-01081-3","article-title":"Improvement in glucose regulation using a digital tracker and continuous glucose monitoring in healthy adults and those with type 2 diabetes","volume":"12","author":"Dehghani Zahedani","year":"2021","journal-title":"Diabetes Ther"},{"key":"2026061016265912100_B33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1210\/clinem\/dgad652","article-title":"Effectiveness of continuous glucose monitoring on metrics of glycemic control in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"109","author":"Uhl","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061016265912100_B34","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"67","author":"Jancev","year":"2024","journal-title":"Diabetologia"},{"key":"2026061016265912100_B35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/dom.15328","article-title":"Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Lu","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026061016265912100_B36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/dia.2023.0390","article-title":"Continuous glucose monitoring systems in noninsulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41591-022-02144-z","article-title":"Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial","volume":"29","author":"Daly","year":"2023","journal-title":"Nat Med"},{"key":"2026061016265912100_B38","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/dom.15462","article-title":"The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes","volume":"26","author":"Reznik","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026061016265912100_B39","doi-asserted-by":"crossref","first-page":"e2459348","DOI":"10.1001\/jamanetworkopen.2024.59348","article-title":"Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial","volume":"8","author":"Pasquel","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026061016265912100_B40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/dom.15993","article-title":"Glycaemic outcomes in adults with type 2 diabetes over 34\u2009weeks with the Omnipod 5 automated insulin delivery system","volume":"27","author":"Davis","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026061016265912100_B41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2337\/cd23-0025","article-title":"Beneficial effects of Control-IQ automated insulin delivery in basal-bolus and basal-only insulin users with type 2 diabetes","volume":"42","author":"Levy","year":"2024","journal-title":"Clin Diabetes"},{"key":"2026061016265912100_B42","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","article-title":"A randomized trial of automated insulin delivery in type 2 diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med"},{"key":"2026061016265912100_B43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/dia.2024.0586","article-title":"Safety and effectiveness of MiniMedTM 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes","volume":"27","author":"Bhargava","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B44","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2337\/dc23-1765","article-title":"Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey","volume":"47","author":"Sherr","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B45","doi-asserted-by":"crossref","first-page":"20420188251346260","DOI":"10.1177\/20420188251346260","article-title":"The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetes","volume":"16","author":"Berry","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2026061016265912100_B46","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00125-024-06240-2","article-title":"Ageing well with diabetes: the role of technology","volume":"67","author":"Maltese","year":"2024","journal-title":"Diabetologia"},{"key":"2026061016265912100_B47","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/dci23-0021","article-title":"The growing role of technology in the care of older adults with diabetes","volume":"46","author":"Huang","year":"2023","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B48","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"key":"2026061016265912100_B49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/dia.2019.0411","article-title":"Increased time in range and fewer missed bolus injections after introduction of a smart connected insulin pen","volume":"22","author":"Adolfsson","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/dc21-1667","article-title":"Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial","volume":"45","author":"McAuley","year":"2022","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B51","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2666-7568(22)00005-8","article-title":"Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study","volume":"3","author":"Boughton","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"2026061016265912100_B52","doi-asserted-by":"crossref","first-page":"EVIDoa2400200","DOI":"10.1056\/EVIDoa2400200","article-title":"Automated insulin delivery in older adults with type 1 diabetes","volume":"4","author":"Kudva","year":"2025","journal-title":"NEJM Evid"},{"key":"2026061016265912100_B53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11892-025-01583-5","article-title":"Managing diabetes in older adults: current approaches in long-term care facilities","volume":"25","author":"Idrees","year":"2025","journal-title":"Curr Diab Rep"},{"key":"2026061016265912100_B54","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1097\/MPA.0000000000002424","article-title":"Evaluating continuous glucose monitoring after total pancreatectomy with or without islet autotransplantation: a scoping systematic review","volume":"54","author":"Bashir","year":"2025","journal-title":"Pancreas"},{"key":"2026061016265912100_B55","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00592-021-01715-9","article-title":"Advanced hybrid closed-loop system: first successful clinical case after total pancreatectomy","volume":"58","author":"Rizzi","year":"2021","journal-title":"Acta Diabetol"},{"key":"2026061016265912100_B56","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamasurg.2022.3702","article-title":"Bihormonal artificial pancreas with closed-loop glucose control vs current diabetes care after total pancreatectomy: a randomized clinical trial","volume":"157","author":"van Veldhuisen","year":"2022","journal-title":"JAMA Surg"},{"key":"2026061016265912100_B57","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/dia.2021.0354","article-title":"The effect of Control IQ hybrid closed loop technology on glycemic control in adolescents and adults with cystic fibrosis-related diabetes","volume":"24","author":"Scully","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcf.2022.07.013","article-title":"Continuous glucose monitoring versus self-monitoring of blood glucose in the management of cystic fibrosis related diabetes: a systematic review and meta-analysis","volume":"22","author":"Kumar","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026061016265912100_B59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/dc23-1411","article-title":"Randomized trial of the insulin-only iLet bionic pancreas for the treatment of cystic fibrosis-related diabetes","volume":"47","author":"Sherwood","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B60","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B61","doi-asserted-by":"crossref","first-page":"101654","DOI":"10.1016\/j.diabet.2025.101654","article-title":"Automated insulin delivery after beta-cell replacement failure in people living with type 1 diabetes","volume":"51","author":"Perrier","year":"2025","journal-title":"Diabetes Metab"},{"key":"2026061016265912100_B62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/JYPL3536","article-title":"Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling","volume":"28","author":"Asgharzadeh","year":"2024","journal-title":"Health Technol Assess"},{"key":"2026061016265912100_B63","doi-asserted-by":"crossref","first-page":"e15432","DOI":"10.1111\/dme.15432","article-title":"Cost-effectiveness of the Tandem t: slim X2 with Control-IQ technology automated insulin delivery system in children and adolescents with type 1 diabetes in Sweden","volume":"41","author":"Adolfsson","year":"2024","journal-title":"Diabet Med"},{"key":"2026061016265912100_B64","first-page":"S21","article-title":"Impact of continuous glucose monitoring on emergency department visits and all-cause hospitalization rates among Medicaid beneficiaries with type 2 diabetes treated with multiple daily insulin or basal insulin therapy","volume":"30","author":"Hirsch","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"2026061016265912100_B65","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s12325-024-02851-8","article-title":"Reduction in diabetes-related hospitalizations and medical costs after Dexcom G6 continuous glucose monitor initiation in people with type 2 diabetes using intensive insulin therapy","volume":"41","author":"Hannah","year":"2024","journal-title":"Adv Ther"},{"key":"2026061016265912100_B66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13300-024-01677-5","article-title":"Cost-effectiveness of FreeStyle Libre for glucose self-management among people with diabetes mellitus: a Canadian private payer perspective","volume":"16","author":"Harris","year":"2025","journal-title":"Diabetes Ther"},{"key":"2026061016265912100_B67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/dia.2022.0271","article-title":"Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre system initiation in people with type 2 diabetes on basal insulin therapy in France","volume":"25","author":"Guerci","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00125-024-06289-z","article-title":"Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA1c and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies","volume":"68","author":"Nathanson","year":"2025","journal-title":"Diabetologia"},{"key":"2026061016265912100_B69","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/dc24-0690","article-title":"Initiation of intermittently scanned continuous glucose monitoring is associated with reduced hospitalization for acute diabetes events and cardiovascular complications in adults with type 1 diabetes","volume":"47","author":"Eeg-Olofsson","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B70","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/dc21-1666","article-title":"Universal subsidized continuous glucose monitoring funding for young people with type 1 diabetes: uptake and outcomes over 2 years, a population-based study","volume":"45","author":"Johnson","year":"2022","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B71","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2337\/dc22-0951","article-title":"Nationally subsidized continuous glucose monitoring: a cost-effectiveness analysis","volume":"45","author":"Pease","year":"2022","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B72","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1159\/000543034","article-title":"International Society for Pediatric and Adolescent Diabetes clinical practice consensus guidelines 2024: diabetes technologies\u2014insulin delivery","volume":"97","author":"Biester","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"2026061016265912100_B73","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2337\/cd23-0092","article-title":"Unleashing the potential of blood glucose monitoring data with the ambulatory glucose profile report","volume":"42","author":"Simonson","year":"2024","journal-title":"Clin Diabetes"},{"key":"2026061016265912100_B74","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3949\/ccjm.91a.23090","article-title":"Using continuous glucose monitoring data in daily clinical practice","volume":"91","author":"Martens","year":"2024","journal-title":"Cleve Clin J Med"},{"key":"2026061016265912100_B75","doi-asserted-by":"crossref","first-page":"e45890","DOI":"10.2196\/45890","article-title":"Disparities in insulin pump use among Spanish-speaking children with type 1 diabetes compared to their non-Hispanic White peers: mixed methods study","volume":"8","author":"Loomba","year":"2023","journal-title":"JMIR Diabetes"},{"key":"2026061016265912100_B76","doi-asserted-by":"crossref","first-page":"e004229","DOI":"10.1136\/bmjdrc-2024-004229","article-title":"Not all healthcare inequities in diabetes are equal: a comparison of two medically underserved cohorts","volume":"12","author":"Walker","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026061016265912100_B77","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/19322968211006476","article-title":"Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the United States: findings from The Gatekeeper Study","volume":"15","author":"Addala","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"2026061016265912100_B78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2337\/dc20-0257","article-title":"A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison","volume":"44","author":"Addala","year":"2021","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B79","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/dia.2022.0042","article-title":"Implicit racial-ethnic and insurance-mediated bias to recommending diabetes technology: insights from T1D Exchange Multicenter Pediatric and Adult Diabetes Provider Cohort","volume":"24","author":"Odugbesan","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/pedi.13139","article-title":"Racial disparities in treatment and outcomes of children with type 1 diabetes","volume":"22","author":"Lipman","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"2026061016265912100_B81","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1111\/dom.15774","article-title":"Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: key themes and evidentiary gaps","volume":"26","author":"Patel","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026061016265912100_B82","doi-asserted-by":"crossref","first-page":"e2445316","DOI":"10.1001\/jamanetworkopen.2024.45316","article-title":"Disparities in continuous glucose monitoring among patients receiving care in federally qualified health centers","volume":"7","author":"Wallia","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026061016265912100_B83","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2337\/cd21-0026","article-title":"Multi-clinic quality improvement initiative increases continuous glucose monitoring use among adolescents and young adults with type 1 diabetes","volume":"39","author":"Prahalad","year":"2021","journal-title":"Clin Diabetes"},{"key":"2026061016265912100_B84","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/dc22-0555","article-title":"Targeting technology in underserved adults with type 1 diabetes: effect of diabetes practice transformations on improving equity in CGM prescribing behaviors [published correction appears in Diabetes Care 2023;46:22]","volume":"46","author":"Mathias","year":"2022","journal-title":"Diabetes Care"},{"key":"2026061016265912100_B85","doi-asserted-by":"crossref","first-page":"102106","DOI":"10.1016\/j.japh.2024.102106","article-title":"Assessment of a community pharmacist remote monitoring service in patients using continuous glucose monitors","volume":"64","author":"Beldon","year":"2024","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2026061016265912100_B86","article-title":"Older adults benefit from virtual support for continuous glucose monitor use but require longer visits","author":"Weinstock","journal-title":"J Diabetes Sci Technol."},{"key":"2026061016265912100_B87","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/ijerph21111420","article-title":"Social media and digital inequity: reducing health inequities by closing the digital divide","volume":"21","author":"Jafar","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"2026061016265912100_B88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11883-024-01249-9","article-title":"Bridging the gap: how accounting for social determinants of health can improve digital health equity in cardiovascular medicine","volume":"27","author":"Kim","year":"2024","journal-title":"Curr Atheroscler Rep"},{"key":"2026061016265912100_B89","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00125-021-05456-w","article-title":"Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin","volume":"64","author":"Reid","year":"2021","journal-title":"Diabetologia"},{"key":"2026061016265912100_B90","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1177\/19322968221101629","article-title":"Health care professionals' perspectives on use of diabetes technologies for managing visually impaired patients with diabetes","volume":"17","author":"Akturk","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"2026061016265912100_B91","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1089\/dia.2021.0524","article-title":"Glycemic outcomes in baseline hemoglobin A1C subgroups in the International Diabetes Closed-Loop Trial","volume":"24","author":"Ekhlaspour","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B92","first-page":"760","article-title":"Candidate selection for hybrid closed loop systems","volume":"23","author":"Forlenza","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B93","doi-asserted-by":"crossref","first-page":"e59824","DOI":"10.2196\/59824","article-title":"Cutaneous adverse effects from diabetes devices in pediatric patients with type 1 diabetes mellitus: systematic review","volume":"7","author":"Podwojniak","year":"2024","journal-title":"JMIR Dermatol"},{"key":"2026061016265912100_B94","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1177\/19322968241253285","article-title":"Device-related skin reactions increase emotional burden in youths with type 1 diabetes and their parents","volume":"18","author":"Passanisi","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"2026061016265912100_B95","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/dia.2022.0513","article-title":"Prevalence and description of the skin reactions associated with adhesives in diabetes technology devices in an adult population: results of the CUTADIAB Study","volume":"25","author":"Diedisheim","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B96","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.57187\/s.3366","article-title":"Impact on diabetes control and patient-reported outcomes of a newer implantable continuous glucose monitoring system (Eversense CGM System): a single-centre retro- and prospective observational study","volume":"154","author":"Rohner","year":"2024","journal-title":"Swiss Med Wkly"},{"key":"2026061016265912100_B97","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1177\/19322968231187661","article-title":"Lipohypertrophy and insulin: an update from the Diabetes Technology Society","volume":"17","author":"Tian","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"2026061016265912100_B98","article-title":"The DERMIS Study: methodologies, results, and implications for the future","author":"Hirsch","year":"2024","journal-title":"J Diabetes Sci Technol."},{"key":"2026061016265912100_B99","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1089\/dia.2018.0080","article-title":"Preserving skin integrity with chronic device use in diabetes","volume":"20","author":"Messer","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B100","unstructured":"Panther.\n          \n          Diabetes technology deciphered. Accessed 11 January 2025. Available from https:\/\/www.pantherprogram.org\/"},{"key":"2026061016265912100_B101","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/dme.14234","article-title":"Psychosocial aspects of diabetes technology","volume":"37","author":"Kubiak","year":"2020","journal-title":"Diabet Med"},{"key":"2026061016265912100_B102","doi-asserted-by":"crossref","first-page":"111566","DOI":"10.1016\/j.diabres.2024.111566","article-title":"Effects of ADHD and ADHD treatment on glycemic management in type 1 diabetes: a systematic review and meta-analysis of observational studies","volume":"209","author":"Zare Dehnavi","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"2026061016265912100_B103","doi-asserted-by":"crossref","first-page":"e15338","DOI":"10.1111\/dme.15338","article-title":"Identifying the deficiencies of currently available CGM to improve uptake and benefit","volume":"41","author":"Barnard-Kelly","year":"2024","journal-title":"Diabet Med"},{"key":"2026061016265912100_B104","first-page":"339","article-title":"Barriers to uptake of insulin technologies and novel solutions","volume":"14","author":"Pauley","year":"2021","journal-title":"Med Devices (Auckl)"},{"key":"2026061016265912100_B105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/dia.2016.0375","article-title":"Insulin pump use in young children with type 1 diabetes: sociodemographic factors and parent-reported barriers","volume":"19","author":"Commissariat","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B106","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1037\/fsh0000485","article-title":"You, me, and diabetes: intimacy and technology among adults with T1D and their partners","volume":"38","author":"Garza","year":"2020","journal-title":"Fam Syst Health"},{"key":"2026061016265912100_B107","doi-asserted-by":"crossref","first-page":"109998","DOI":"10.1016\/j.diabres.2022.109998","article-title":"How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod 5 System","volume":"190","author":"Polonsky","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2026061016265912100_B108","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12916-024-03396-x","article-title":"Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes","volume":"22","author":"Ng","year":"2024","journal-title":"BMC Med"},{"key":"2026061016265912100_B109","doi-asserted-by":"crossref","first-page":"e14863","DOI":"10.1111\/dme.14863","article-title":"Real-world prospective observational single-centre study: hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers","volume":"39","author":"Ng","year":"2022","journal-title":"Diabet Med"},{"key":"2026061016265912100_B110","doi-asserted-by":"crossref","first-page":"e43535","DOI":"10.2196\/43535","article-title":"Improvement of selected psychological parameters and quality of life of patients with type 1 diabetes mellitus undergoing transition from multiple daily injections and self-monitoring of blood glucose directly to the MiniMed 780G advanced hybrid closed-loop system: post hoc analysis of a randomized control study","volume":"7","author":"Cyranka","year":"2023","journal-title":"JMIR Form Res"},{"key":"2026061016265912100_B111","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/dom.15351","article-title":"Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial","volume":"26","author":"Reznik","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026061016265912100_B112","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00431-024-05551-1","article-title":"The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes","volume":"183","author":"Jalilova","year":"2024","journal-title":"Eur J Pediatr"},{"key":"2026061016265912100_B113","doi-asserted-by":"crossref","first-page":"e15425","DOI":"10.1111\/dme.15425","article-title":"The emotional burden of type 1 diabetes: a cross-sectional study to understand associations between diabetes distress and glucose metrics in adulthood","volume":"41","author":"Kelly","year":"2024","journal-title":"Diabet Med"},{"key":"2026061016265912100_B114","doi-asserted-by":"crossref","first-page":"e080053","DOI":"10.1136\/bmjopen-2023-080053","article-title":"Associations between use of diabetes technology and diabetes distress: a Danish cross-sectional survey of adults with type 1 diabetes","volume":"14","author":"Lorenzen","year":"2024","journal-title":"BMJ Open"},{"key":"2026061016265912100_B115","doi-asserted-by":"crossref","first-page":"e15312","DOI":"10.1111\/dme.15312","article-title":"Roles and competencies of the clinical psychologist in adult diabetes care\u2014a consensus report","volume":"41","author":"Snoek","year":"2024","journal-title":"Diabet Med"},{"key":"2026061016265912100_B116","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/1753-0407.13454","article-title":"Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: a systematic review of qualitative studies","volume":"15","author":"Natale","year":"2023","journal-title":"J Diabetes"},{"key":"2026061016265912100_B117","doi-asserted-by":"crossref","first-page":"e14906","DOI":"10.1111\/dme.14906","article-title":"The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes","volume":"39","author":"Fallon","year":"2022","journal-title":"Diabet Med"},{"key":"2026061016265912100_B118","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11892-022-01470-3","article-title":"The use of diabetes technology to address inequity in health outcomes: limitations and opportunities","volume":"22","author":"Agarwal","year":"2022","journal-title":"Curr Diab Rep"},{"key":"2026061016265912100_B119","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/dia.2013.0192","article-title":"Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey","volume":"16","author":"Pickup","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B120","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/dia.2016.07281.sf","article-title":"Insulin infusion set use: European perspectives and recommendations","volume":"18","author":"Deiss","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B121","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"key":"2026061016265912100_B122","doi-asserted-by":"crossref","first-page":"1464365","DOI":"10.3389\/fcdhc.2024.1464365","article-title":"The success of insulin pump therapy: importance of education of patients and health professionals","volume":"5","author":"Cari\u0107","year":"2024","journal-title":"Front Clin Diabetes Healthc"},{"key":"2026061016265912100_B123","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1043659617723074","article-title":"Participation of racial and ethnic minorities in technology-based interventions to self-manage type 2 diabetes: a scoping review","volume":"29","author":"Jang","year":"2018","journal-title":"J Transcult Nurs"},{"key":"2026061016265912100_B124","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1932296820963630","article-title":"Clouds and silver linings: COVID-19 pandemic is an opportune moment to democratize diabetes care through telehealth","volume":"14","author":"Kerr","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2026061016265912100_B125","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1089\/tmj.2023.0270","article-title":"Telemedicine for the underserved racial and ethnic minorities during COVID-19 and beyond","volume":"30","author":"Sarwal","year":"2024","journal-title":"Telemed J E Health"},{"key":"2026061016265912100_B126","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/1932296820932903","article-title":"Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic","volume":"14","author":"Galindo","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2026061016265912100_B127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MED.0000000000000693","article-title":"Continuous glucose monitoring in the hospital: an update in the era of COVID-19","volume":"29","author":"Gothong","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2026061016265912100_B128","doi-asserted-by":"crossref","first-page":"e2336876","DOI":"10.1001\/jamanetworkopen.2023.36876","article-title":"Comprehensive telehealth model to support diabetes self-management","volume":"6","author":"Aleppo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026061016265912100_B129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/tmj.2024.0093","article-title":"Patient-reported outcomes improve with a virtual diabetes care model that includes continuous glucose monitoring","volume":"31","author":"Hood","year":"2025","journal-title":"Telemed J E Health"},{"key":"2026061016265912100_B130","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.3390\/jcm13237359","article-title":"Telemedicine for managing type 1 diabetes in children and adolescents before and after the COVID-19 pandemic","volume":"13","author":"Fogliazza","year":"2024","journal-title":"J Clin Med"},{"key":"2026061016265912100_B131","doi-asserted-by":"crossref","first-page":"100686","DOI":"10.1016\/j.lanepe.2023.100686","article-title":"Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study","volume":"32","author":"Dardari","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2026061016265912100_B132","doi-asserted-by":"crossref","first-page":"e58441","DOI":"10.2196\/58441","article-title":"A remote patient monitoring system with feedback mechanisms using a smartwatch: concept, implementation, and evaluation based on the activeDCM randomized controlled trial","volume":"12","author":"Wettstein","year":"2024","journal-title":"JMIR Mhealth Uhealth"},{"key":"2026061016265912100_B133","first-page":"1","article-title":"Remote monitoring of implantable cardioverter-defibrillators, cardiac resynchronization therapy and permanent pacemakers: a health technology assessment","volume":"18","author":"Health Quality Ontario","year":"2018","journal-title":"Ont Health Technol Assess Ser"},{"key":"2026061016265912100_B134","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3390\/s24092675","article-title":"A multi-faceted digital health solution for monitoring and managing diabetic foot ulcer risk: a case series","volume":"24","author":"Matijevich","year":"2024","journal-title":"Sensors (Basel)"},{"key":"2026061016265912100_B135","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/clinem\/dgab859","article-title":"Teamwork, targets, technology, and tight control in newly diagnosed type 1 diabetes: the pilot 4T Study","volume":"107","author":"Prahalad","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061016265912100_B136","first-page":"e64928","article-title":"Evaluating the impact of telemedicine on diabetes management in rural communities: a systematic review","volume":"16","author":"AlQassab","year":"2024","journal-title":"Cureus"},{"key":"2026061016265912100_B137","doi-asserted-by":"crossref","first-page":"e64635","DOI":"10.2196\/64635","article-title":"Differences in telemedicine use for patients with diabetes in an academic versus safety net health system: retrospective cohort study","volume":"27","author":"Shih","year":"2025","journal-title":"J Med Internet Res"},{"key":"2026061016265912100_B138","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00125-023-06049-5","article-title":"A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU\/UK\/US perspective","volume":"67","author":"Jendle","year":"2024","journal-title":"Diabetologia"},{"key":"2026061016265912100_B139","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/dia.2024.0073","article-title":"Point-counterpoint: the need for do-it-yourself (DIY) open source (OS) AID systems in type 1 diabetes management","volume":"26","author":"Forlenza","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026061016265912100_B140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmpb.2016.06.006","article-title":"Model individualization for artificial pancreas","volume":"171","author":"Messori","year":"2019","journal-title":"Comput Methods Programs Biomed"},{"key":"2026061016265912100_B141","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/btm2.10119","article-title":"Multivariate learning framework for long-term adaptation in the artificial pancreas","volume":"4","author":"Shi","year":"2019","journal-title":"Bioeng Transl Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/6\/916\/858500\/dci260018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/6\/916\/858500\/dci260018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:27:18Z","timestamp":1781123238000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/6\/916\/164559\/Challenges-in-and-Opportunities-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":141,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,12]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci26-0018","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}